{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:44:29Z","timestamp":1790196269626,"version":"4.1.0"},"reference-count":125,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Interstitial lung diseases (ILDs) that are known as diffuse parenchymal lung diseases (DPLDs) lead to the damage of alveolar epithelium and lung parenchyma, culminating in inflammation and widespread fibrosis. ILDs that account for more than 200 different pathologies can be divided into two groups: ILDs that have a known cause and those where the cause is unknown, classified as idiopathic interstitial pneumonia (IIP). IIPs include idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP), cryptogenic organizing pneumonia (COP) known also as bronchiolitis obliterans organizing pneumonia (BOOP), acute interstitial pneumonia (AIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), and lymphocytic interstitial pneumonia (LIP). In this review, our aim is to describe the pathogenic mechanisms that lead to the onset and progression of the different IIPs, starting from IPF as the most studied, in order to find both the common and standalone molecular and cellular key players among them. Finally, a deeper molecular and cellular characterization of different interstitial lung diseases without a known cause would contribute to giving a more accurate diagnosis to the patients, which would translate to a more effective treatment decision.<\/jats:p>","DOI":"10.3390\/ijms22168952","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T08:44:45Z","timestamp":1629449085000},"page":"8952","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players"],"prefix":"10.3390","volume":"22","author":[{"given":"Anna Valeria","family":"Samarelli","sequence":"first","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-0758","authenticated-orcid":false,"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marchioni","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bruzzi","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Gozzi","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Andrisani","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Castaniere","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Manicardi","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moretti","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tabb\u00ec","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cerri","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Begh\u00e8","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Oncology Unit, University Hospital of Modena, University of Modena and Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-5094","authenticated-orcid":false,"given":"Enrico","family":"Clini","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy"},{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"American Thoracic Society Documents An Official American Thoracic Society\/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-020-1296-3","article-title":"Progression of fibrosing interstitial lung disease","volume":"21","author":"Wong","year":"2020","journal-title":"Respir. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s40265-019-01178-x","article-title":"Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)","volume":"79","author":"Jee","year":"2019","journal-title":"Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","article-title":"Interstitial lung disease in connective tissue disease-Mechanisms and management","volume":"10","author":"Wells","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","first-page":"1","article-title":"Interstitial lung diseases in developing countries","volume":"85","year":"2019","journal-title":"Ann. Glob. Health"},{"key":"ref_7","first-page":"193","article-title":"Asbestosis and environmental causes of usual interstitial pneumonia","volume":"21","author":"Gulati","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_8","first-page":"1","article-title":"Identifying causation in hypersensitivity pneumonitis: A British perspective","volume":"6","author":"Barber","year":"2019","journal-title":"BMJ Open Respir. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: The ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An Official ATS\/ERS\/JRS\/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis an international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","first-page":"343","article-title":"Pulmonary fibrosis, part I: Epidemiology, pathogenesis, and diagnosis","volume":"11","author":"Meyer","year":"2017","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105803","DOI":"10.1016\/j.rmed.2019.105803","article-title":"Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment","volume":"159","author":"Cerri","year":"2019","journal-title":"Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0845-5","article-title":"The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Guenther","year":"2018","journal-title":"Respir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/resp.12674","article-title":"Idiopathic non-specific interstitial pneumonia","volume":"21","author":"Belloli","year":"2016","journal-title":"Respirology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/0100-3984.2016.0134","article-title":"Idiopathic interstitial pneumonias: Review of the latest American Thoracic Society\/European Respiratory Society classification","volume":"51","author":"Oliveira","year":"2018","journal-title":"Radiol. Bras."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccm.2016.04.009","article-title":"Lymphocytic Interstitial Pneumonia","volume":"37","author":"Panchabhai","year":"2016","journal-title":"Clin. Chest Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis An Official ATS\/ERS\/JRS\/ALAT Clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1148\/rg.2015140334","article-title":"American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002","volume":"35","author":"Sverzellati","year":"2015","journal-title":"Radiographics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200310-1436ST","article-title":"Diagnosis and initial management of nonmalignant diseases related to asbestos","volume":"170","author":"Guidotti","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","article-title":"Silicosis","volume":"379","author":"Leung","year":"2012","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ebner, L., Christodoulidis, S., Stathopoulou, T., Geiser, T., Stalder, O., Limacher, A., Heverhagen, J.T., Mougiakakou, S.G., and Christe, A. (2020). Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP). PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226084"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"109482","DOI":"10.1016\/j.cellsig.2019.109482","article-title":"The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis","volume":"66","author":"Selman","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1165\/rcmb.2020-0373PS","article-title":"The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis","volume":"64","author":"Pardo","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201910-1958OC","article-title":"Genome-wide association study: Functional variant rs2076295 regulates desmoplakin expression in airway epithelial cells","volume":"202","author":"Hao","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286S","article-title":"The myofibroblast in pulmonary fibrosis","volume":"122","author":"Phan","year":"2002","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","article-title":"Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-\u03b21: Potential role in idiopathic pulmonary fibrosis","volume":"166","author":"Willis","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"Phillips","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1164\/rccm.201212-2297OC","article-title":"Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis","volume":"188","author":"Hung","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1513\/pats.201202-017AW","article-title":"Mechanical aspects of lung fibrosis: A spotlight on the myofibroblast","volume":"9","author":"Hinz","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.ajpath.2016.07.004","article-title":"Lung Pericytes and Resident Fibroblasts: Busy Multitaskers","volume":"186","author":"Barron","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105595","DOI":"10.1016\/j.biocel.2019.105595","article-title":"Fibrocytes and fibroblasts\u2014Where are we now","volume":"116","author":"Chong","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_35","first-page":"4139","article-title":"Evidence for the involvement of fibroblast growth factor 10 in lipofibroblast formation during embryonic lung Development","volume":"142","author":"Sakurai","year":"2015","journal-title":"Development"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"C684","DOI":"10.1152\/ajpcell.00114.2014","article-title":"ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling","volume":"307","author":"Marriott","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1096\/fj.13-236828","article-title":"Wilms\u2019 tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis","volume":"28","author":"Karki","year":"2014","journal-title":"FASEB J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI85328","article-title":"Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis","volume":"126","author":"Xie","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases\u2014subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: A randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ccm.2021.03.002","article-title":"Diagnostic Classification of Interstitial Lung Disease in Clinical Practice","volume":"42","author":"Adegunsoye","year":"2021","journal-title":"Clin. Chest Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1148\/radiol.2361031674","article-title":"Idiopathic interstitial pneumonias: CT features","volume":"236","author":"Lynch","year":"2005","journal-title":"Radiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","article-title":"Idiopathic nonspecific interstitial pneumonia: Report of an American Thoracic Society Project","volume":"177","author":"Travis","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","first-page":"101077","article-title":"Respiratory Medicine Case Reports Acute interstitial pneumonia triggered by strenuous exercise","volume":"30","author":"Markoska","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.sult.2013.10.007","article-title":"Syndrome, Acute Interstitial Pneumonia","volume":"35","author":"Ichikado","year":"2014","journal-title":"Semin. Ultrasound CT MRI"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"190181","DOI":"10.1183\/16000617.0181-2019","article-title":"Desquamative interstitial pneumonia: A systematic review of its features and outcomes","volume":"29","author":"Hellemons","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_47","first-page":"291","article-title":"Review Interstitial lung disease in Sj\u00f6gren \u2019 s syndrome: A clinical review","volume":"38","author":"Luppi","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13244-014-0335-3","article-title":"Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): A pictorial review","volume":"5","author":"Palmucci","year":"2014","journal-title":"Insights Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kusagaya, H., Nakamura, Y., Kono, M., Kaida, Y., Kuroishi, S., Enomoto, N., Fujisawa, T., Koshimizu, N., Yokomura, K., and Inui, N. (2012). Idiopathic pleuroparenchymal fibroelastosis: Consideration of a clinicopathological entity in a series of Japanese patients. BMC Pulm. Med., 12.","DOI":"10.1186\/1471-2466-12-72"},{"key":"ref_50","first-page":"181","article-title":"Stem cells and cell therapies in lung biology and diseases: Conference report","volume":"12","author":"Fomby","year":"2010","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pardo, A., Gibson, K., Cisneros, J., Richards, T.J., Yang, Y., Becerril, C., Yousem, S., Herrera, I., Ruiz, V., and Selman, M. (2005). Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020251"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physiol.00033.2018","article-title":"Mechanisms for the resolution of organ fibrosis","volume":"34","author":"Horowitz","year":"2019","journal-title":"Physiology"},{"key":"ref_53","first-page":"616","article-title":"TGFbeta signalling in context","volume":"13","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1096\/fj.12-224907","article-title":"Profibrotic TGF\u03b2 responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases","volume":"27","author":"Andrianifahanana","year":"2013","journal-title":"FASEB J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.1208","article-title":"MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis","volume":"198","author":"Yoshida","year":"2002","journal-title":"J. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Madala, S.K., Schmidt, S., Davidson, C., Ikegami, M., Wert, S., and Hardie, W.D. (2011). MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation. Am. J. Respir. Cell Mol. Biol., 46.","DOI":"10.1165\/rcmb.2011-0237OC"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73752-3","article-title":"Spred2-deficiency enhances the proliferation of lung epithelial cells and alleviates pulmonary fibrosis induced by bleomycin","volume":"10","author":"Kawara","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting Proteostasis for Disease Intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Sontake, V., Jegga, A.G., Madala, S.K., Sontake, V., Wang, Y., Kasam, R.K., Sinner, D., and Reddy, G.B. (2017). Hsp90 regulation of fibroblast activation in pulmonary fibrosis Hsp90 regulation of fibroblast activation in pulmonary fibrosis. JCI Insight.","DOI":"10.1172\/jci.insight.91454"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1183\/13993003.02152-2016","article-title":"Heat shock protein: A hot topic in idiopathic pulmonary fibrosis","volume":"49","author":"Bonniaud","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01902148.2020.1764148","article-title":"Post-treatment with a heat shock protein 90 inhibitor prevents chronic lung injury and pulmonary fibrosis, following acute exposure of mice to HCl","volume":"46","author":"Marinova","year":"2020","journal-title":"Exp. Lung Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Colunga Biancatelli, R.M.L., Solopov, P., Gregory, B., and Catravas, J.D. (2020). Hsp90 inhibition and modulation of the proteome: Therapeutical implications for idiopathic pulmonary fibrosis (ipf). Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155286"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ajpath.2012.08.019","article-title":"The hedgehog system machinery controls transforming growth factor-\u03b2-dependent myofibroblastic differentiation in humans: Involvement in idiopathic pulmonary fibrosis","volume":"181","author":"Cigna","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1152\/ajplung.00184.2012","article-title":"Role of Sonic Hedgehog in idiopathic pulmonary fibrosis","volume":"303","author":"Milla","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.1074\/jbc.M111.276311","article-title":"Interactions Between \u03b2-Catenin and Transforming Growth Factor-\u03b2 Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Element-binding Protein (CREB)-binding Protein (CBP)","volume":"287","author":"Zhou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-016-0334-7","article-title":"Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts","volume":"17","author":"Hasaneen","year":"2016","journal-title":"Respir. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"109588","DOI":"10.1016\/j.cellsig.2020.109588","article-title":"Chronic WNT\/\u03b2-catenin signaling induces cellular senescence in lung epithelial cells","volume":"70","author":"Lehmann","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41374-019-0316-8","article-title":"The Shh\/Gli signaling cascade regulates myofibroblastic activation of lung-resident mesenchymal stem cells via the modulation of Wnt10a expression during pulmonary fibrogenesis","volume":"100","author":"Cao","year":"2020","journal-title":"Lab. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","article-title":"Pathogenesis of fibrosis: Role of TGF-\u03b2 and CTGF: Current Opinion i... Current Opinion in Rheumatology: Pathogenesis of fibrosis: Role of TGF-\u03b2 and CTGF","volume":"14","author":"Ihn","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-020-01467-0","article-title":"CXCR4+cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis","volume":"21","author":"Jaffar","year":"2020","journal-title":"Respir. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25964","DOI":"10.1074\/jbc.M113.459784","article-title":"Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption","volume":"288","author":"Herrera","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Noguchi, S., Saito, A., and Nagase, T. (2018). YAP\/TAZ signaling as a molecular link between fibrosis and cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113674"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e98738","DOI":"10.1172\/jci.insight.98738","article-title":"Active epithelial Hippo signaling in idiopathic pulmonary fibrosis","volume":"3","author":"Gokey","year":"2018","journal-title":"JCI Insight"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.90558","article-title":"Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis","volume":"1","author":"Xu","year":"2016","journal-title":"JCI Insight"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.128674","article-title":"RESEARCH ARTICLE TAZ is required for lung alveolar epithelial cell differentiation after injury","volume":"4","author":"Sun","year":"2019","journal-title":"JCI Insight"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dev.193458","article-title":"Stem cells in pulmonary alveolar regeneration","volume":"148","author":"Wu","year":"2021","journal-title":"Development"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.stem.2016.10.004","article-title":"Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis Article Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung","volume":"20","author":"Moiseenko","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Bartis, D., Crowley, L.E., D\u2019Souza, V.K., Borthwick, L., Fisher, A.J., Croft, A.P., Pongr\u00e1cz, J.E., Thompson, R., Langman, G., and Buckley, C.D. (2016). Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis. BMC Pulm. Med., 16.","DOI":"10.1186\/s12890-016-0211-7"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"240ra76","DOI":"10.1126\/scitranslmed.3007096","article-title":"Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in mammalian lung fibrosis","volume":"6","author":"Zhou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Schupp, J.C., Binder, H., J\u00e4ger, B., Cillis, G., Zissel, G., M\u00fcller-Quernheim, J., and Prasse, A. (2015). Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116775"},{"key":"ref_84","first-page":"1397","article-title":"Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis","volume":"40","author":"Samara","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.immuni.2016.01.001","article-title":"Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis","volume":"44","author":"Deshane","year":"2016","journal-title":"Immunity"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yamashita, M., Saito, R., Yasuhira, S., Fukuda, Y., Sasamo, H., Sugai, T., Yamauchi, K., and Maemondo, M. (2018). Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias. J. Immunol. Res., 2018.","DOI":"10.1155\/2018\/1436236"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kreuter, M., Bonella, F., Wijsenbeek, M., Maher, T.M., and Spagnolo, P. (2015). Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/329481"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fi brosis ( CAPACITY ): Two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/13543784.2020.1773790","article-title":"Pamrevlumab for the treatment of idiopathic pulmonary fibrosis","volume":"29","author":"Sgalla","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): A phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/pr.114.009381","article-title":"The rho kinases: Critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis","volume":"67","author":"Knipe","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"107798","DOI":"10.1016\/j.pharmthera.2020.107798","article-title":"Idiopathic pulmonary fibrosis: Disease mechanisms and drug development","volume":"222","author":"Spagnolo","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.201207-1204PP","article-title":"Mesenchymal stem cells and idiopathic pulmonary fibrosis potential for clinical testing","volume":"188","author":"Toonkel","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.201302-0351ED","article-title":"Cell therapy trials for lung diseases: Progress and cautions","volume":"188","author":"Weiss","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Moodley, Y., Vaghjiani, V., Chan, J., Baltic, S., Ryan, M., Tchongue, J., Samuel, C.S., Murthi, P., Parolini, O., and Manuelpillai, U. (2013). Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069299"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.692551","article-title":"Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution","volume":"12","author":"Samarelli","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.127.1.266","article-title":"Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis","volume":"127","author":"Plataki","year":"2005","journal-title":"Chest"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jcp.2004.022632","article-title":"The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia","volume":"58","author":"Nakashima","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1164\/rccm.200112-123OC","article-title":"Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred","volume":"165","author":"Thomas","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jprot.2013.04.033","article-title":"Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors","volume":"85","author":"Korfei","year":"2013","journal-title":"J. Proteom."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17208-1","article-title":"Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles","volume":"7","author":"Peng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0857-1","article-title":"Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis","volume":"19","author":"Cecchini","year":"2018","journal-title":"Respir. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0040-1708499","article-title":"Nonspeci fi c Interstitial Pneumonia","volume":"41","author":"Teoh","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): A phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/resp.12786","article-title":"Acute and subacute idiopathic interstitial pneumonias","volume":"21","author":"Taniguchi","year":"2016","journal-title":"Respirology"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Li, H., Zhang, J., Song, X., Wang, T., Li, Z., Hao, D., Wang, X., and Zheng, Q. (2014). Alveolar epithelial cells undergo epithelial-mesenchymal transition in acute interstitial pneumonia: A case report. BMC Pulm. Med., 14.","DOI":"10.1186\/1471-2466-14-67"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"E1475","DOI":"10.1073\/pnas.1117988108","article-title":"Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition","volume":"108","author":"Rock","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384101.2019.1578144","article-title":"Up-regulation of THY1 attenuates interstitial pulmonary fibrosis and promotes lung fibroblast apoptosis during acute interstitial pneumonia by blockade of the WNT signaling pathway lung fibroblast apoptosis during acute interstitial pneumonia by blockade","volume":"18","author":"Chen","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1096\/fj.12-206458","article-title":"General mechanisms of nicotine-induced fibrogenesis","volume":"26","author":"Jensen","year":"2012","journal-title":"FASEB J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1378\/chest.15-0409","article-title":"Infl ammatory diseases of the lung induced by conventional cigarette smoke a review","volume":"148","author":"Alexander","year":"2015","journal-title":"Chest"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.rmed.2013.06.004","article-title":"CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases","volume":"107","author":"Cai","year":"2013","journal-title":"Respir. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-genom-082908-150046","article-title":"Syndromes of telomere shortening","volume":"10","author":"Armanios","year":"2009","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis","volume":"356","author":"Alder","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/rccm.200804-550OC","article-title":"Telomere shortening in familial and sporadic pulmonary fibrosis","volume":"178","author":"Cronkhite","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Patel, A.S., Lin, L., Geyer, A., Haspel, J.A., An, C.H., Cao, J., Rosas, I.O., and Morse, D. (2012). Autophagy in idiopathic pulmonary fibrosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041394"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/resp.12576","article-title":"Smoking-related idiopathic interstitial pneumonia: A review","volume":"21","author":"Margaritopoulos","year":"2016","journal-title":"Respirology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1183\/09059180.00003112","article-title":"An integrated approach in the diagnosis of smoking-related interstitial lung diseases","volume":"21","author":"Caminati","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1378\/chest.122.6.2150","article-title":"Lymphoid interstitial pneumonia: A narrative review","volume":"122","author":"Swigris","year":"2002","journal-title":"Chest"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2559.1995.tb00247.x","article-title":"Reactive pulmonary lymphoid disorders","volume":"26","author":"Nicholson","year":"1995","journal-title":"Histopathology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"691","DOI":"10.5858\/134.5.691","article-title":"Update on nonneoplastic pulmonary lymphoproliferative disorders and related entities","volume":"134","author":"Guinee","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01032-2","article-title":"ROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs","volume":"8","author":"Mrass","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01327","article-title":"Pulmonary manifestations of primary sj\u00f6gren\u2019s syndrome: Underlying immunological mechanisms, clinical presentation, and management","volume":"10","author":"Gupta","year":"2019","journal-title":"Front. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8952\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:47:37Z","timestamp":1760165257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":125,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22168952"],"URL":"https:\/\/doi.org\/10.3390\/ijms22168952","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,19]]}}}